Male Patients with Cancer at Higher Risk of Severe Disease Course and Mortality Attributable to COVID-19

Findings from a systematic review and meta-analysis

Foundation Medicine wins FDA OK for pan-cancer liquid biopsy test

The FDA approved the second comprehensive “liquid biopsy” platform that can detect multiple kinds of cancer from tumor DNA circulating in a patient’s blood.

Cancer Control Continuum | DCCPS/NCI/NIH

View the cancer control continuum, a framework on which to view plans, progress, and priorities.

Two Immunotherapies Merge Into Single, More Effective… : Oncology Times

An abstract is unavailable.

A Study of the Omentum in Ovarian Cancer : Oncology Times

An abstract is unavailable.

Obesity and Cancer: It’s Causal and…Reversible?

Click on the article title to read more.

Agenus Announces ESMO Oral Presentation of Two Clinical Trials of Balstilimab Alone and in Combination with Zalifrelimab in Recurrent or Metastatic Cervical Cancer

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapy, adjuvants, and vaccines designed to activate immune response to cancers…

Cancer Incidence Rates – SEER Cancer Statistics

Definition and explanation of cancer incidence rate.

Addressing Racism & Racial Inequities in Cancer Research : Oncology Times

An abstract is unavailable.

Online Event